Exploring the Drug delivery systems of Natural products on inflammation-mediated Disorders: a short Note

Abstract

Advancements in diagnostic tools and clinical procedures have unveiled much about the causes and workings of these conditions. In vitro and in vivo experimental models have paved the way for numerous biomedical breakthroughs, notably in discovering potential drugs to tackle metabolic disorders. Natural compounds have garnered attention as promising candidates due to their antioxidant and anti-inflammatory properties, offering hope for managing conditions like diabetes, obesity, heart diseases, and cancer. Efforts are ongoing to enhance the effectiveness and availability of these compounds through specialized drug delivery methods. Our focus delves into the recent strides made in understanding how inflammatory responses kickstart metabolic disorders, especially in diabetes, obesity, heart diseases, and cancer. We explore the potential of natural products in combating these conditions and provide a roster of biological targets for efficient screening in drug development. Furthermore, we discuss insights gained from both preclinical and clinical studies, aiming to pinpoint optimal approaches for using phytochemical drug delivery systems in treating metabolic disorders. This comprehensive review aims to shed light on the latest developments and potential avenues in addressing the complexities of metabolic disorders through innovative drug strategies.